Weight Loss for Men After 45, Measured Before It Is Prescribed
Most men who arrive here have already done the obvious things. They eat less than they did at 30, they move more than their fathers did, and the waist keeps going the wrong way anyway. The usual response in this category is to skip straight to the prescription.
We do not. A GLP-1 is often the right tool for a man after 45, and a poor one when the thing driving the weight is something it does not touch: a testosterone problem, a thyroid problem, untreated sleep apnea, a medication, or a drinking pattern nobody asked about. After 45, men lose lean mass and gain midsection fat even at a stable weight, testosterone drifts down while visceral fat pushes it lower, and insulin resistance gets more common (the full physiology is on our weight gain pages). More variables than at 30, so they are measured first, by name, and the plan is built around what comes back.
What we measure before a GLP-1 is chosen
Every ACT 2 patient starts with the same baseline panel: metabolic markers, the full lipid picture, liver and kidney function, thyroid, inflammatory markers, nutrient status and hormones. For a man after 45 who has come for weight loss, these get the closest reading.
Testosterone, read correctly. One afternoon reading is how a lot of men get told they are "low" or "fine" when neither is established. The Endocrine Society's guideline ties a diagnosis of hypogonadism to symptoms plus consistently low morning values on more than one occasion, and the American Urological Association's guideline takes the same two-measurement position. Getting the test right.
SHBG, because weight distorts the number. Sex hormone-binding globulin carries most testosterone in the blood, and excess weight and insulin resistance push it down, so a heavier man's total testosterone can look low while his free testosterone is adequate. The Endocrine Society guideline advises measuring free testosterone when SHBG is likely altered, and names obesity among the causes.
Thyroid. Hypothyroidism is a treatable cause of weight gain and fatigue, and NIDDK notes it becomes more common with age. It is checked before anyone concludes the problem is appetite.
Insulin resistance. Fasting glucose, A1c and fasting insulin tell us whether the midsection fat is a symptom as well as a cause; NIDDK describes waist fat as both a driver and a marker of insulin resistance.
Sleep apnea. No blood test measures it, so we ask: snoring, witnessed pauses, waking unrefreshed, nodding off in the afternoon. The National Heart, Lung, and Blood Institute lists excess weight as a leading risk factor, and untreated apnea works against weight loss through hunger, fatigue and lower testosterone. If the answers point that way, a sleep study is a referral, and it matters more than the prescription. Do I have sleep apnea?
Alcohol. It is calories, it breaks up sleep, and at high volumes it suppresses testosterone. The honest number of drinks a week is part of the intake, without judgment, using the NIAAA's screening questions.
When low testosterone is addressed first, or alongside
Testosterone replacement is not a weight-loss treatment. It is prescribed for men with confirmed low testosterone: symptoms plus consistently low morning readings, with the reversible causes considered first. The Endocrine Society and the AUA both frame it that way, and so do we. A man whose testosterone is low because he carries visceral fat, sleeps badly and drinks most nights has what endocrinologists call functional hypogonadism, and Grossmann and Matsumoto's review in the Journal of Clinical Endocrinology and Metabolism is direct: for those men, weight loss and treating the underlying condition comes first, and often raises testosterone on its own.
In practice there are three paths.
Weight first. Testosterone is borderline, the man is heavy, and there is a clear reversible driver. The weight program runs and the hormone markers are rechecked as the weight comes down. When your level is borderline.
Both, together. Testosterone is unequivocally low on repeat testing, symptoms are consistent, and the reversible causes have been addressed. TRT can then be prescribed alongside the weight plan by the same clinician, managed as one case. Confirmed low testosterone is the indication; the weight is the other program's job.
Hormones first. Less common: low testosterone with a cause that will not move with weight loss, such as a pituitary issue or a medication that is suppressing it. That is a different workup and sometimes a referral.
What we will not do is sell testosterone as the thing that fixes the belly. Men over 45 are the exact market that pitch is aimed at, and the guidelines are clear it is the wrong order of operations.
Protecting muscle while the weight comes off
Men like to believe muscle loss on a diet is a women's problem. It is not. Rapid weight loss by any route, including GLP-1s, takes lean mass along with fat, and after 45 it is harder to rebuild. Conte and colleagues' 2025 review puts it plainly: in older adults, losing weight without protecting muscle can trade one problem for another. Sarcopenia is the end of that road; how it hides inside an ordinary-looking weight is on muscle loss versus fat gain. Three things protect it, and none is optional here.
Protein, at every meal. Appetite falls on a GLP-1, and when men eat less they drop protein first, because it is the part of the plate that takes effort. We set a protein target with each patient and check it at every follow-up. You will not find a figure here: the right amount depends on your weight, your kidney function and your training.
Strength training, not more cardio. The Physical Activity Guidelines for Americans ask every adult to include muscle-strengthening work and add balance work for older adults. Cardio is good for your heart and nearly useless for keeping muscle in a deficit. Progressive resistance work a few times a week is the highest-return thing a man on a GLP-1 can do.
Monitoring, not hoping. The scale cannot tell you what you lost. We track waist, grip strength and how your lifts are moving. Body composition testing is a referral where it would change the plan, since we do not perform DEXA. If strength is falling while weight is falling, the pace is too fast, and we slow it.
What the first three months look like
Month one. Labs, the intake above, and a live visit with a licensed clinician. If a GLP-1 is prescribed, it starts at the lowest step; if testosterone is confirmed low and TRT is appropriate, that decision is made in the same visit. The strength and protein plan starts the same week.
Month two. First follow-up: side effects, protein, training, sleep and alcohol, with the medication step adjusted by the clinician on tolerance, not on a calendar. Men on TRT have recheck labs scheduled.
Month three. Waist and strength against baseline, and for men who started "weight first" with a borderline result, a repeat hormone panel is considered. Anything not moving gets a reason, not a shrug.
What it costs
ACT 2's semaglutide and tirzepatide are compounded. The price includes the medication, the live clinician visit and home delivery if prescribed, as a monthly subscription you can cancel.
- Semaglutide injection: $299 a month, or $550 for a two-month package ($275 a month). Semaglutide details.
- Tirzepatide injection: $399 a month, or $750 for two months. It costs more than semaglutide, and your clinician chooses between them on clinical grounds, not price. Tirzepatide cost in detail.
- TRT program, for men with confirmed low testosterone: $249 for the first month, which includes the lab panel, then $149 a month on refill or $450 for three months. TRT cost in detail.
- Baseline lab panel on its own: $199, one time, if you want the picture before deciding on any treatment.
New patients: $100 off your first month for new patients on either GLP-1. That offer cannot be combined with the 10% welcome code, so use whichever saves you more. The welcome code does not apply to labs.
Who this suits, and who it does not
It suits a man over 45 who has gained weight he cannot shift, is willing to lift and eat protein, and wants to know whether his hormones and thyroid are part of the story before he commits to a medication.
It does not suit a man who wants the injection without the labs or the follow-ups, or who wants testosterone prescribed because he is tired and heavy rather than because it has been measured and confirmed. We will say no to both, politely.
When a GLP-1 is not the answer, or not yet:
- Untreated sleep apnea. The sleep study comes first. Treating apnea improves energy, appetite and testosterone, and a GLP-1 layered on top of it underperforms.
- Heavy alcohol use. Nausea and dehydration get worse when a GLP-1 meets a heavy drinking pattern, sleep stays broken, and the calories keep coming in. The drinking is the conversation to have first.
- A medication causing the gain. Some antidepressants, beta blockers and steroids add weight. If one of yours is on that list, the first move is a conversation with the prescriber, not a second drug. Medications that cause weight gain.
- A history of disordered eating. A medication that suppresses appetite can reactivate restriction. We ask, and if the answer is yes, a GLP-1 is not the right first step.
Frequently asked questions
The medication is not, but what is measured around it should be. For a man over 45, testosterone, SHBG and the sleep apnea screen carry more weight in the workup, and muscle preservation is a bigger concern than most men expect. The drugs themselves are covered on the semaglutide and tirzepatide pages.
For many men whose level is low because of excess weight, yes, at least partly; Grossmann and Matsumoto's review describes weight loss as the first-line approach to functional hypogonadism for that reason. It is not guaranteed. A man whose testosterone stays low after meaningful weight loss has a clearer case for treatment than before.
Yes, when testosterone is confirmed low on repeat morning testing with consistent symptoms, and the clinician judges both appropriate; we manage them as one case. What we do not do is prescribe TRT as a shortcut to weight loss. It is prescribed for low testosterone, and the weight program handles the weight.
Visceral fat is metabolically active and tends to run with insulin resistance, lower testosterone and worse sleep, each of which makes it harder to lose. That is the loop the baseline labs are designed to see. The causes are covered in depth on weight gain.
Some, on any weight-loss plan that works, and more if it is fast and unsupported. The amount depends on your protein intake, your training and the pace of loss, which is why those three are tracked. If strength is dropping, we slow the loss.
Yes. We will not prescribe a GLP-1, and certainly not testosterone, without them, because the labs are what tell us which problem you actually have. If you only want the picture, the baseline panel is available on its own at $199.
Where this fits in your plan
Start with the baseline panel and a candid intake about sleep and drinking. From there, the weight loss program is built around what came back, and TRT is on the table only where low testosterone has been confirmed.
We measure first. Then we act.
References
- Bhasin S et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Endocrine Society, 2018. https://www.endocrine.org/clinical-practice-guidelines/testosterone-therapy
- Mulhall JP et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. American Urological Association, 2018. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
- Grossmann M, Matsumoto AM. A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management. Journal of Clinical Endocrinology and Metabolism, 2017. https://pmc.ncbi.nlm.nih.gov/articles/PMC5477803/
- Insulin Resistance and Prediabetes. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/diabetes/overview/what-is-diabetes/prediabetes-insulin-resistance
- Hypothyroidism (Underactive Thyroid). National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/endocrine-diseases/hypothyroidism
- Sleep Apnea. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/sleep-apnea
- Understanding Alcohol Use Disorder. National Institute on Alcohol Abuse and Alcoholism. https://www.niaaa.nih.gov/alcohols-effects-health/alcohol-use-disorder
- Conte C et al. Sarcopenic obesity and weight loss-induced muscle mass loss. Current Opinion in Clinical Nutrition and Metabolic Care, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12147736/
- Physical Activity Guidelines for Americans. U.S. Department of Health and Human Services. https://odphp.health.gov/our-work/nutrition-physical-activity/physical-activity-guidelines
- Back toFor Men
- Low testosteroneWhat low testosterone actually looks like after 40, what else produces the same picture, and how it is properly measured.Read
- Muscle loss versus fat gainThe scale adds up four things and reports one number. What body composition shows instead, how to track it, and why muscle is the thing to defend.Read
- Do I have sleep apnea?Most sleep apnea is never diagnosed, and most of it does not look like the stereotype. What raises suspicion — and why it is the first thing to exclude.Read
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
Diagnostic testing does not diagnose or rule out disease on its own and is interpreted by a licensed provider alongside your history and examination.
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.